Key result
This review discusses the current medical management, catheter-directed therapies, and surgical embolectomy for patients with massive pulmonary embolism.
This article reviews the current medical management, catheter-directed therapies, and surgical embolectomy for the treatment of patients with massive pulmonary embolism.
Answers are grounded in this paper and cite their sources.
May support catheter-directed options in massive PE with thrombolysis contraindications; leaves open need for RCTs.
Massive pulmonary embolus (PE), defined as hemodynamic shock from acute PE, is a life-threatening condition. Deaths from massive PE, especially when unsuspected, occur within minutes to hours of onset and as such prompt intervention can be lifesaving. Acute massive PE patients have traditionally been candidates for treatment with intravenous systemic thrombolysis to improve pulmonary artery pressure, arteriovenous oxygenation, and pulmonary perfusion in an effort to reduce mortality. However, patients with contraindications to systemic thrombolysis or those who have failed thrombolysis may benefit from other techniques including endovascular and surgical embolectomy. This article will review the current medical management as well as catheter-directed therapies and surgical embolectomy in the treatment of patients with massive PE.
No takes yet. Share an insight, caveat, or question.
Edwards et al. (2018) conducted a review in Massive pulmonary embolus (PE). Catheter-directed therapies and surgical embolectomy vs. Systemic thrombolysis was evaluated. This review discusses the current medical management, catheter-directed therapies, and surgical embolectomy for patients with massive pulmonary embolism.
Synapse has enriched 10 related papers. Consider them for comparative context: